Jesús Cebrecos

6PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)PainCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 04, 2024
E-52862-A selective sigma-1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double-blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy.

Rafael Gálvez, Victor Mayoral, Jesús Cebrecos

|Sep 24, 2024
Safety of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: Pooled Analysis of Three Phase 3 Randomized Trials.

Eugene R Viscusi, Richard Langford, Adelaida Morte

|Jul 03, 2024
Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial.

Eugene R Viscusi, Oscar de Leon-Casasola, Jesús Cebrecos

|Jun 14, 2024
Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials.

Richard Langford, Eugene R Viscusi, Adelaida Morte

|Aug 17, 2022
Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: A randomized, double-blind, phase 3 trial (STARDOM2).

Richard Langford, Adelaida Morte, Mariano Sust

|Jun 10, 2022
Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: A phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial.

Eugene R Viscusi, Oscar de Leon-Casasola, Jesús Cebrecos

Pageof 1

Frequent Collaborators

6 joint publications

Adelaida Morte

6 joint publications

Mariano Sust

5 joint publications

Anna Vaqué

4 joint publications

Eugene R Viscusi